CUSIP: 75973T101
What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 75973T101:
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Renalytix plc - ADS (RNLXY).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$2,630 | $0.20 | 0 |
| 2025 Q3 | 10,000 | $2,630 | $0.26 | 1 | |
| 2025 Q2 | 10,000 | $1,850 | $0.18 | 1 | |
| 2025 Q1 | 10,000 | $2,200 | -$11,454 | $0.22 | 1 |
| 2024 Q4 | 67,068 | $13,555 | -$870,873 | $0.21 | 3 |
| 2024 Q3 | 3,496,554 | $883,839 | +$38,822 | $0.21 | 22 |
| 2024 Q2 | 3,334,562 | $771,644 | -$1,152,969 | $0.23 | 22 |
| 2024 Q1 | 4,014,918 | $3,445,201 | -$129,671 | $0.86 | 23 |
| 2023 Q4 | 4,955,989 | $1,930,158 | -$299,938 | $0.39 | 24 |
| 2023 Q3 | 4,492,705 | $7,187,581 | +$1,425,380 | $1.60 | 26 |
| 2023 Q2 | 3,567,423 | $10,415,025 | +$818,688 | $2.92 | 20 |
| 2023 Q1 | 3,290,829 | $7,961,875 | +$161,636 | $2.42 | 18 |
| 2022 Q4 | 3,444,225 | $6,439,824 | -$1,916,928 | $1.87 | 20 |
| 2022 Q3 | 4,404,591 | $5,637,000 | -$3,180,156 | $1.28 | 25 |
| 2022 Q2 | 5,685,796 | $13,929,330 | -$2,019,598 | $2.45 | 31 |
| 2022 Q1 | 6,326,983 | $43,781,000 | +$1,987,432 | $6.92 | 33 |
| 2021 Q4 | 6,009,450 | $95,550,000 | -$8,699,989 | $15.90 | 33 |
| 2021 Q3 | 6,062,678 | $121,556,000 | -$455,619 | $20.05 | 31 |
| 2021 Q2 | 5,945,890 | $183,490,000 | +$1,385,984 | $30.86 | 39 |
| 2021 Q1 | 5,931,986 | $152,213,000 | +$28,111,522 | $25.66 | 35 |
| 2020 Q4 | 4,848,420 | $77,575,000 | -$1,523,390 | $16.00 | 19 |
| 2020 Q3 | 4,902,426 | $59,767,000 | +$59,767,000 | $12.19 | 15 |
| 2020 Q2 | 3,150 | $21,000 | +$21,000 | $6.67 | 1 |